Cargando…
Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial
BACKGROUND AND THE PURPOSE OF THE STUDY: Diabetic neuropathy is the most common diabetic complication that often is accompanied by significant morbidity, mortality and economic burden. The purpose of this study was evaluation of effect of Semelil (ANGIPARS™), a new herbal drug for treatment of diabe...
Autores principales: | Bakhshayeshi, S., Madani, SP., Hemmatabadi, M., Heshmat, R., Larijani, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232074/ https://www.ncbi.nlm.nih.gov/pubmed/22615641 |
Ejemplares similares
-
The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2012) -
Effects of Semelil (ANGIPARS™) on focal cerebral ischemia in male rats
por: Asadi-Shekaari, M, et al.
Publicado: (2010) -
Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury
por: Joukar, Siyavash, et al.
Publicado: (2013) -
The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
por: Tabatabaei-Malazy, O, et al.
Publicado: (2011) -
Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy
por: Fateh, Hamid R., et al.
Publicado: (2016)